Schering-Plough Has 4th-Qtr Profit on Lower Tax Costs (Update1) Bloomberg.com - Jan 30 4:38 AM Jan. 30 (Bloomberg) — Schering-Plough Corp. said it had a fourth-quarter profit on lower tax costs and higher sales of the Vytorin and Zetia cholesterol drugs and Remicade rheumatoid arthritis treatment.Save to My Web
Cholesterol fighter bolsters earnings The Star-Ledger - Jan 30 10:57 PM Schering-Plough reported a fourth-quarter profit yesterday, boosted by a strong performance of its cholesterol-fighting drugs and lower income taxes.Save to My Web
Drug Combo Works Best for Rheumatoid Arthritis Forbes - Jan 9, 2006 of anti-TNF (tumor necrosis factor) and DMARD (disease-modifying antirheumatic drug) therapies achieved remission of early rheumatoid arthritis better than
Another use for statins - treating rheumatoid arthritis News-Medical.net, Australia - Jan 31, 2006 widely used to treat high cholesterol, have a potential role in inflammation and other cell processes, including immune response and rheumatoid arthritis.
Drugmakers'4Q Profit, Revenue Rises MSN MoneyCentral - TRENTON, N.J. (AP) - Schering-Plough Corp. reported a fourth-quarter profit Monday, boosted by a strong performance of its cholesterol-fighting drugs and lower income taxes. Meanwhile, Paris-based Sanofi-Aventis SA, the world's third-largest
